Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -215.61% is 29% below its 5-year average of -167.00%, around the middle of its 5-year range (-584.42%–-21.57%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.37% below its 12-month average of -173.37%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -215.61%.
RETURN ON INVESTED CAPITAL (ROIC)
-215.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-173.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-171.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-167.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-179.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-24.37%
CURRENT VS 3Y AVG
-25.87%
CURRENT VS 5Y AVG
-29.11%
CURRENT VS 10Y AVG
-20.29%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 766 covered companies
CURRENT VS SECTOR MEDIAN
-526.14%
vs the sector median at left
MetaVia Inc.
Market Cap
$9.78M
Return on Invested Capital (ROIC)
-215.61%
TTM Avg
-173.37%
3Y Avg
-171.29%
5Y Avg
-167.00%
Market Cap
$9.76M
Return on Invested Capital (ROIC)
-80.51%
TTM Avg
-60.18%
3Y Avg
-50.63%
5Y Avg
-247.68%
Market Cap
$9.57M
Return on Invested Capital (ROIC)
-183.45%
TTM Avg
-213.20%
3Y Avg
-179.79%
5Y Avg
-169.02%
Market Cap
$10.08M
Return on Invested Capital (ROIC)
-269.16%
TTM Avg
-387.93%
3Y Avg
-400.47%
5Y Avg
-400.47%
Market Cap
$9.37M
Return on Invested Capital (ROIC)
-325.63%
TTM Avg
-111.28%
3Y Avg
-111.28%
5Y Avg
-230.14%
Market Cap
$9.14M
Return on Invested Capital (ROIC)
-11.06%
TTM Avg
-74.47%
3Y Avg
-55.02%
5Y Avg
-81.57%
Market Cap
$10.33M
Return on Invested Capital (ROIC)
-227.67%
TTM Avg
-121.58%
3Y Avg
-92.03%
5Y Avg
-78.85%
Market Cap
$10.34M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-27.20%
3Y Avg
-100.49%
5Y Avg
-187.87%
Market Cap
$9.17M
Return on Invested Capital (ROIC)
-1394.09%
TTM Avg
-237.25%
3Y Avg
-170.48%
5Y Avg
-138.64%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MetaVia Inc. (MTVA) | $9.78M | -215.61% | -173.37% | -171.29% | -167.00% |
| Ainos, Inc. (AIMD)vs › | $9.76M | -80.51% | -60.18% | -50.63% | -247.68% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.57M | -183.45% | -213.20% | -179.79% | -169.02% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.08M | -269.16% | -387.93% | -400.47% | -400.47% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.37M | -325.63% | -111.28% | -111.28% | -230.14% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.14M | -11.06% | -74.47% | -55.02% | -81.57% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.33M | -227.67% | -121.58% | -92.03% | -78.85% |
| Polyrizon Ltd. (PLRZ)vs › | $10.34M | N/A | -27.20% | -100.49% | -187.87% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.17M | -1394.09% | -237.25% | -170.48% | -138.64% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.44M | -59.35% | -68.11% | -104.39% | -133.77% |
ROIC
-215.6%
ROE
-211.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -215.61% |
| 2026-03-31 | -149.42% |
| 2025-12-31 | -21.57% |
| 2025-09-30 | -272.42% |
| 2025-06-30 | -207.81% |
| 2025-03-31 | -584.42% |
| 2024-12-31 | -360.61% |
| 2024-09-30 | -221.69% |
| 2024-06-30 | -139.31% |
| 2024-03-31 | -198.64% |
| 2023-12-31 | -94.44% |
| 2023-09-30 | -95.14% |
| 2023-06-30 | -78.82% |
| 2023-03-31 | -93.98% |
| 2022-12-31 | -90.24% |
| 2022-09-30 | -232.00% |
| 2022-06-30 | -160.04% |
| 2022-03-31 | -124.05% |
| 2021-12-31 | -104.30% |
| 2021-09-30 | -489.56% |
| 2021-06-30 | -312.83% |
| 2021-03-31 | -214.11% |
| 2020-12-31 | -408.58% |
| 2020-09-30 | -239.07% |
| 2020-06-30 | -189.17% |
| 2020-03-31 | -293.65% |
| 2019-12-31 | -167.06% |
| 2019-06-30 | -689.66% |
| 2019-03-31 | -409.18% |
| 2018-12-31 | -174.91% |
| 2018-09-30 | -124.54% |
| 2018-06-30 | -113.71% |
| 2018-03-31 | -105.66% |
| 2017-12-31 | -236.90% |
| 2017-09-30 | -169.64% |
| 2017-06-30 | -161.56% |
| 2017-03-31 | -78.95% |
| 2016-12-31 | -71.23% |
| 2016-09-30 | -36.98% |
| 2016-06-30 | -264.12% |
| 2015-12-31 | -404.41% |
